HuGE Literature Finder
Records
1
-
4
Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families. BMC cancer 2019 Apr 19 (1): 313. Shahi Rajendra Bahadur, De Brakeleer Sylvia, Caljon Ben, Pauwels Ingrid, Bonduelle Maryse, Joris Sofie, Fontaine Christel, Vanhoeij Marian, Van Dooren Sonia, Teugels Erik, De Grève Jacqu |
Common TDP1 Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium. Clinical cancer research : an official journal of the American Association for Cancer Research 2017 Oct . Lohavanichbutr Pawadee, Sakoda Lori C, Amos Christopher I, Arnold Susanne M, Christiani David C, Davies Michael P A, Field John K, Haura Eric B, Hung Rayjean J, Kohno Takashi, Landi Maria Teresa, Liu Geoffrey, Liu Yi, Marcus Michael W, O'Kane Grainne M, Schabath Matthew B, Shiraishi Kouya, Slone Stacey A, Tardon Adonina, Yang Ping, Yoshida Kazushi, Zhang Ruyang, Zong Xuchen, Goodman Gary G, Weiss Noel S, Chen C |
Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan. Pharmacogenomics 2009 Jul 10 (7): 1139-46. Hoskins Janelle M, Rosner Gary L, Ratain Mark J, McLeod Howard L, Innocenti Federi |
Irinotecan pharmacogenetics: influence of pharmacodynamic genes. Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Mar 14 (6): 1788-96. Hoskins Janelle M, Marcuello Eugenio, Altes Albert, Marsh Sharon, Maxwell Taylor, Van Booven Derek J, Paré Laia, Culverhouse Robert, McLeod Howard L, Baiget Montserr |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 26, 2023
- Content source: